Woman’s cancer killed by measles virus in trial
I am curious about the timescale of treatments for terminal diseases, and how trials can be morally randomised.<p>It seems to me that a very high percentage of people would opt for a potentially fatal, completely untested course of action as opposed to imminent death. So who gets to try these treatments, who tells dying patients they are not allowed them, and is there a black market or large amounts of money changing hands for experimental procedures?<p>Ekianjo in this thread quoted 7 years at the earliest for a treatment to become available. Surely with hundreds of thousands of desperate, dying, last chance sufferers, it is better to go to extreme measures and offer the most promising yet dangerous treatments to everyone. Is it simply a side effect of the way pharmaceutical companies have to do business? If so, it's sad, and maybe a larger share of cancer research money should be put towards 'out there' attempts to cure terminal patients.<p>Genuinely curious.